Embecta's most recent quarterly report didn't give investors much to be exicited about.

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter ...

Embecta shares fell sharply premarket after the maker of medical supplies lowered growth projections for the fiscal year and reduced its quarterly dividend on the heels of weak second-quarter earnings ...

Q2 fiscal 2026 Management View "This was a difficult quarter for embecta." (President, CEO & Chairman Devdatt Kurdikar) "Our results were below expectations with consolidated revenues down 14.4% ...

Embecta (NASDAQ:EMBC) reported fiscal second-quarter 2026 results that fell short of expectations, driven primarily by U.S. weakness in its pen needle business, and lowered its full-year outlook while ...

The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each ...

Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

Shares are trading at a reported 4.1x forward earnings, offer a 5.2% dividend yield, and the stock is down more than 40% YTD, thus representing a fat discount to recent prices. Seems like a bargain at ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...

On April 13, Mizuho lowered its price recommendation on Embecta Corp. (NASDAQ:EMBC) to $12 from $14. It reiterated a Neutral rating on the shares. The change came as the firm adjusted estimates and ...

Embecta Corp. (NASDAQ:EMBC) is included among the 10 Healthcare Stocks with Highest Dividends. On April 13, Mizuho lowered its price recommendation on Embecta Corp. (NASDAQ:EMBC) to $12 from $14. It ...